Dzudie Anastase, Rayner Brian, Ojji Dike, Schutte Aletta E, Twagirumukiza Marc, Damasceno Albertino, Ba Seringe Abdou, Kane Abdoul, Kramoh Euloge, Kacou Jean Baptiste, Onwubere Basden, Cornick Ruth, Sliwa Karen, Anisiuba Benedict, Mocumbi Ana Olga, Ogola Elijah, Awad Mohamed, Nel George, Otieno Harun, Toure Ali Ibrahim, Kingue Samuel, Kengne Andre Pascal, Perel Pablo, Adler Alma, Poulter Neil, Mayosi Bongani
Department of Internal Medicine, Yaoundé Faculty of Medicine and Biomedical Sciences, Yaoundé, Cameroon; Department of Medicine, University of Cape Town, Cape Town, South Africa; Hatter Institute for Cardiovascular Research in Africa, Department of Medicine, Groote Schuur Hospital, University of Cape Town, Cape Town, South Africa.
Division of Nephrology and Hypertension, Department of Medicine, Groote Schuur Hospital and University of Cape Town, Cape Town, South Africa.
Cardiovasc J Afr. 2017 Jul/Aug;28(4):262-272. doi: 10.5830/CVJA-2017-040.
The Pan-African Society of Cardiology (PASCAR) has identified hypertension as the highest area of priority for action to reduce heart disease and stroke on the continent. The aim of this PASCAR roadmap on hypertension was to develop practical guidance on how to implement strategies that translate existing knowledge into effective action and improve detection, treatment and control of hypertension and cardiovascular health in sub-Saharan Africa (SSA) by the year 2025.
Development of this roadmap started with the creation of a consortium of experts with leadership skills in hypertension. In 2014, experts in different fields, including physicians and non-physicians, were invited to join. Via faceto-face meetings and teleconferences, the consortium made a situation analysis, set a goal, identified roadblocks and solutions to the management of hypertension and customised the World Heart Federation roadmap to Africa.
Hypertension is a major crisis on the continent but very few randomised, controlled trials have been conducted on its management. Also, only 25.8% of the countries have developed or adopted guidelines for the management of hypertension. Other major roadblocks are either government and health-system related or healthcare professional or patient related. The PASCAR hypertension task force identified a 10-point action plan to be implemented by African ministries of health to achieve 25% control of hypertension in Africa by 2025.
Hypertension affects millions of people in SSA and if left untreated, is a major cause of heart disease and stroke. Very few SSA countries have a clear hypertension policy. This PASCAR roadmap identifies practical and effective solutions that would improve detection, treatment and control of hypertension on the continent and could be implemented as is or adapted to specific national settings.
泛非心脏病学会（PASCAR）已将高血压确定为该大陆减少心脏病和中风行动的最高优先领域。这份PASCAR高血压路线图的目标是制定实用指南，说明如何实施将现有知识转化为有效行动的策略，并到2025年改善撒哈拉以南非洲（SSA）地区高血压的检测、治疗和控制以及心血管健康状况。
该路线图的制定始于创建一个由具有高血压领域领导技能的专家组成的联盟。2014年，邀请了包括医生和非医生在内的不同领域的专家加入。通过面对面会议和电话会议，该联盟进行了形势分析、设定了目标、确定了高血压管理的障碍和解决方案，并对世界心脏联盟的路线图进行了非洲本土化定制。
高血压是该大陆的一个重大危机，但针对其管理的随机对照试验却很少。此外，只有25.8%的国家制定或采用了高血压管理指南。其他主要障碍要么与政府和卫生系统有关，要么与医疗保健专业人员或患者有关。PASCAR高血压特别工作组确定了一项十点行动计划，供非洲各国卫生部实施，以在2025年实现非洲25%的高血压控制率。
高血压影响着撒哈拉以南非洲地区数百万人，如果不加以治疗，是心脏病和中风的主要原因。撒哈拉以南非洲地区很少有国家有明确的高血压政策。这份PASCAR路线图确定了切实有效的解决方案，这些方案将改善该大陆高血压的检测、治疗和控制，并且可以直接实施或根据具体国情进行调整。
